Founded by two experts in pharmacology and pharmacoepidemiology, Qualissima is composed of a multi-skilled and experienced team, enabling us to offer our customers full benefits in clinical studies.
Olivier Blin is a University Professor – Hospital Practitioner, Clinical Pharmacologist and neuropsychiatrist. He is in charge of the Center of Clinical Pharmacology and Therapeutic Evaluations at the Assistance-Publique-Hôpitaux of Marseille.
He is also responsible for the Team Feelings Pharmacology and Physiopathology within the " Institute of the Cognitive Neurosciences of the Mediterranean , UMR CNRS 6193".
Olivier Blin a is member of the American Society for Clinical Pharmacology and Therapeutics and of the American College of Clinical Pharmacology, past-president of the French Association of Biological Psychiatry, Secretary of the Clinical Pharmacology Section of the French Society of Pharmacology and Therapeutics.
Sophie Tardieu is a pharmacist, former Hospital resident and Hospital Practitioner in Public Health. She brings her methodological support in the field of the pharmaco epidemiology and of the medical evaluation. She is a member of the French Society of Pharmacology and Therapeutics.
Romain Combalat owns a Master's degree in Sciences. After the obtention of his Diploma: "Investigators training for clinical trials" (DIU-FIEC), he joined Qualissima in September 2008 as Clinical Research Associate.
Nowadays, he manages the clinical operations and ensures the operational management of the company (human resources, administrative aspects, financial aspects, and marketing).
Magali Comte owns a thesis in Neurosciences.
After training as a CRA at ClinAct Paris and Qualissima, she has joined the company in October 2016 as Clinical Research Associate.